Letter to the editor: Outcome of Chelidonium majus (greater celandine) for COVID-19
Der Merkurstab 2023;76(1):53.
Article-ID: DMS-21597-EN
DOI: https://doi.org/10.14271/DMS-21597-EN
1 Gardin NE, Braga AJ. Greater celandine (Chelidonium majus L.) for COVID-19: a twenty-case series. Phytotherapy Research 2021;35(7):3792–3798. DOI: https://doi.org/10.1002/ptr.7085. [Crossref]
2 Gardin NE, Grines SA, Braga AJ. Chelidonium majus and the image of COVID-19. Der Merkurstab 2021;74(5):404–410. DOI: https://doi.org/10.14271/DMS-21406-EN.
3 European Medicines Agency. Committee on Herbal Medicinal Products. Assessment Report on Chelidonium majus L., herba [monography on the Internet]. Amsterdam: European Medicines Agency; 2012. Available at https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-chelidonium-majus-l-herba_en.pdf (11.11.2022).